Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium

Author:

Obermayr Eva1,Bednarz-Knoll Natalia2,Orsetti Beatrice34,Weier Heinz-Ulrich5,Lambrechts Sandrina6,Castillo-Tong Dan Cacsire1,Reinthaller Alexander1,Braicu Elena Ioana7,Mahner Sven89,Sehouli Jalid7,Vergote Ignace6,Theillet Charles34,Zeillinger Robert1,Brandt Burkhard10

Affiliation:

1. Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria

2. Institute of Tumor Biology, University Medical Center Eppendorf, Hamburg, Germany

3. INSERM U1194, IRCM, Université de Montpellier, Montpellier, France

4. Institut du Cancer de Montpellier, Montpellier, France

5. Department of Cancer and DNA Damage Responses, Life Sciences Division, University of California, Lawrence Berkeley National Laboratory, Berkeley, CA, USA

6. Division of Gynecological Oncology, Department of Obstetrics and Gynecology, Leuven Cancer Institute, University Hospitals Leuven, Katholieke Universiteit Leuven, Leuven, Belgium

7. Department of Gynecology, European Competence Center for Ovarian Cancer, Campus Virchow Klinikum, Charité- Universitätsmedizin Berlin, Berlin, Germany

8. Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

9. Department of Gynecology and Obstetrics, University of Munich, Munich, Germany

10. Institute of Clinical Chemistry, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3